» Articles » PMID: 28321922

Retrospective Evaluation of Venous Thromboembolism: Are All Transient Provoking Events the Same?

Overview
Journal Eur J Haematol
Specialty Hematology
Date 2017 Mar 22
PMID 28321922
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Venous thromboembolism (VTE) provoked by transient risk factors has traditionally been classified as a single entity with lower risk of recurrence. We evaluated the association between different categories of transient provoking factors and the relative risk of recurrence.

Methods: Retrospective evaluation of VTE events in non-cancer patients from July 2011 to December 2012 at two tertiary institutions in Australia with a minimum follow-up of 24 months.

Results: A total of 747 VTE cases were identified, and following exclusion of cases with mortality within 30 days of presentation (n=26), unprovoked cases (40.2%) had a higher risk of recurrence (4.6 vs 2.3/100 event-years, P=.01). Provoking factors included surgery (40.4%), injury (16.7%), medical-related factors including non-surgical hospitalisation or active infection (22.0%), travel (13.2%) and oestrogen related (6.5%). Air travel had the highest recurrence rate of 5.9/100 event-years, comparable to unprovoked VTE. VTE provoked by surgery showed lower recurrence rate at 1.8/100 event-years (P=.03). 62.5% of patients with provoked VTE recurred with an unprovoked event.

Conclusion: Transient provoking factors for VTE are heterogeneous with varying potency and should not be considered a single entity. The high recurrence rate after travel-provoked VTE suggests that it is a "minor," if not negligible provoking factor with higher thrombotic predisposition.

Citing Articles

Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines.

Djulbegovic B, Hozo I, Guyatt G Blood Adv. 2024; 8(13):3596-3606.

PMID: 38625997 PMC: 11319831. DOI: 10.1182/bloodadvances.2024012931.


Provoked vs minimally provoked vs unprovoked VTE: does it matter?.

Becattini C, Cimini L Hematology Am Soc Hematol Educ Program. 2023; 2023(1):600-605.

PMID: 38066936 PMC: 10727063. DOI: 10.1182/hematology.2023000492.


Incidence and Predictors of Recurrence and Mortality Following First Venous Thromboembolism Among the Saudi Population: Single-Center Cohort Study.

AlEidan F, AlManea R, AlMoneef A, Shalash N, AlRajhi N, AlMousa S Int J Gen Med. 2022; 15:7559-7568.

PMID: 36199587 PMC: 9527814. DOI: 10.2147/IJGM.S359893.


Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?.

Ozen G, Pedro S, Schumacher R, Simon T, Michaud K RMD Open. 2021; 7(2).

PMID: 34193517 PMC: 8246357. DOI: 10.1136/rmdopen-2021-001618.


Lab-on-a-Chip for Cardiovascular Physiology and Pathology.

Beverung S, Wu J, Steward Jr R Micromachines (Basel). 2020; 11(10).

PMID: 32998305 PMC: 7600691. DOI: 10.3390/mi11100898.